Widespread Usage of HPV Vaccine Reduces Cervical Cancers and Precancers

HPV (Human Papillomavirus) is a common virus that affects most people at some point in their lifetime. Almost 200 different types of strains are found related to the HPV that are characterized on the basis of low to high risk. HPV strains with low risk do not cause any harm but can cause conditions like genital warts. Whereas, HPV strains with high risk can cause serious health problems like Cervical Cancers. In women, Cervical Cancer is considered to be the most common cancer, because most cervical cancers are caused to due to the Human papillomavirus (HPV).


The risk of HPV infection will remain at high risk in women, that most commonly includes Cervical cancers. Around 100 types of HPV strains have been identified to date, out of which approximately 15 virus strains are known to cause Cervical Cancer. Cervical Cancer is caused due by HPV types 16 and 18. The vaccines available for HPV infections can protect from various strains that can cause Cervical cancer.


Cervical cancer is the second leading cause of death due to cancer in women, who are in their 20s and 30s. The HPV vaccine can help people protect from several other types of HPV infections that can cause cervical cancer and other types of cancer such as - Penis, Vaginal, anus, and mouth cancers. The first-ever vaccine which was developed protects from the types 16 and 18 of the HPV strains that cause Cervical cancer. Whereas the vaccines that are produced now protect from almost 9 types of HPV strains.


HPV Vaccination 


Vaccinations provided at the recommended age will be more beneficial to help prevent the widespread of cancer strains, than vaccination at older ages. The HPV administration has recommended an HPV vaccination age of 9-12 years, which will help to stabilize the stains at an early age. Also, vaccinating at an early age will also help in the prevention of Cervical Cancer Caused by HPV strains.


FDA has approved 3 types of HPV vaccines named - Gardasil, Gardasil 9, and Cervarix that are available to protect from the infections. In the United States since 2016, Gardasil 9 is the only vaccine used against HPV infections. Whereas, 3 of them are commonly used in the United Kingdom. The companies manufacturing the vaccines are - Gardasil (Merck), Gardasil 9 (Merck), and Cervarix (gsk).


Salient Factors Of HPV Vaccine


As discussed the HPV vaccine provides protection from many types of cancer strains such as - cervical cancer, anal, and mouth cancers. Some of the factors for the HPV vaccine include -


  • The first vaccine for HPV infection was available in the year 2006

  • HPV vaccination is considered to be the part of routine vaccination in every country

  • The HPV vaccine provides protection from 9 types of HPV strains for almost 5-10 years

  • After the vaccine is injected mild symptoms like -  swelling, redness, and pain in the injected area can be felt for some time


What Lies Ahead For HPV Vaccination 


As per the research, the Incidence of Cervical cancer is the second leading cause of death in women infected with cancers. The 9 valent HPV vaccine is currently working well in preventing the high-grade cervical strains as well as providing immunity from the advanced cervical cancer strains. In the current situation, almost countries have begun using HPV vaccination as a regular routine of their vaccination schedule, which helps WHO to plan out things for the elimination of HPV strains and cancer caused due to the strains.


To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services


Also, take a glance at the market insights reports by DelveInsight:

Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market


Comments

Popular posts from this blog

Innovations in Surgical Cameras and Their Impact on Healthcare

What is Chronic Wounds and why is its market booming?

Condom Market Report 2028: Market Size, Trends, and Forecast